Navigation Links
Varian Software Successfully Connected with Siemens Linear Accelerators
Date:6/13/2013

PALO ALTO, Calif., June 13, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and Siemens Healthcare today announced that clinicians at The Ohio State University (Ohio State) are now using Varian software to plan and manage radiotherapy treatments delivered on a Siemens medical linear accelerator.  The companies have developed and deployed an interface that connects Varian's ARIA® oncology information system with Siemens' ONCOR and PRIMUS accelerators and imaging systems.

"Since we launched the global strategic partnership with Siemens last year, we have been steadily working to develop software interfaces that enable clinics with Siemens linear accelerators to manage patient care using Varian software," says Kolleen Kennedy, president of Varian's Oncology Systems business.  "With this new interface, we can connect to about 80 percent of the Siemens equipment in the field.  Now the majority of Siemens-equipped sites can choose to adopt ARIA for managing all aspects of care, from initial diagnosis through post-treatment follow-up."

In March of this year, Siemens received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for connectivity between Varian's ARIA software and Siemens' ONCOR and PRIMUS linear accelerators. 

"Developing these interfaces was one of our main goals when we launched our partnership last year," says Walter Maerzendorfer, CEO of Siemens Computed Tomography and Radiation Oncology.  "We're pleased to have now released this interface and completed the first deployment at such a luminary U.S. treatment center.  We would like to thank the team at The Ohio State University for valuable clinical input during the interface development process, and for helping our teams identify ways of enhancing the workflow wh
'/>"/>

SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
2. Emerging Targeted Therapies Offer Efficacy Advantages Over Currently Used Chemotherapies for Platinum-Resistant Advanced Ovarian Cancer
3. Preclinical and Phase 1 Data of VTX-2337 Presented at 2013 ASCO Annual Meeting Shows Early Activity in Ovarian Cancer
4. Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System
5. Vermillion Supports First World Ovarian Cancer Day and Effort to Raise Awareness of the Need for Better Diagnosis and Treatment
6. Varian Enables HIPAA Compliance and Optimizes Customer Service with the Axeda Machine Cloud
7. Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
8. UK Hospitals Order All Varian TrueBeam Radiotherapy Systems Offered Under Government Stimulus Program
9. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2013
10. Cancer Experts Detail Advanced Radiosurgery Treatments for Lung Cancer Using Varian Medical Systems Technologies
11. Varian Medical Systems Spotlights Industry-Leading Motion Management and Radiosurgery Technologies at ESTRO 2013 in Geneva
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 Patterson Medical, ... (Nasdaq: PDCO ), is now an independent ... acquisition of Patterson Medical by Madison Dearborn Partners ... its name for a transition period before rebranding ... and sports medicine products.  With the focused resources ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by Pharmacia & ... receptor agonist which effectively reduces intraocular pressure. As ... latanoprost (under the trade name of Xalatan) entered ...
(Date:8/28/2015)... 28, 2015  IP Shakti, LLC, today announced that it ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... new corporate identity signifies our transformation into a company focused ... platform for patent claim validity." ... proprietary AIA Shield™ platform, the Company commenced a corporate re-branding ...
Breaking Medicine Technology:Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3China Latanoprost Market Investigation Report 2015-2019 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
... Diversifies Revenue Streams and Boosts Scale in Existing Generics ... Expected to be Immediately Accretive to Adjusted Diluted Earnings per ... Company Reiterates Full-Year 2010 Financial Guidance ... today that it has entered into a definitive agreement to ...
... (Nasdaq: DCTH ) announced today that management will ... Tuesday, October 5, 2010 at 8:45 a.m. ET in New ... an overview of the Company,s business strategy and recent corporate ... only. Delcath will offer a live audio webcast of its ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 2Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 3Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 4Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 5Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 6Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 7Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 8Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 9Delcath to Present at the William Blair Emerging Growth Stock Conference 2
(Date:8/30/2015)... ... ... Scientists in France say asbestos exposure may put workers at higher risk for ... posted an article on the new research. Click here to read it now. ... French asbestos plant workers from 1978 to 2009. In addition to mesothelioma, the workers ...
(Date:8/30/2015)... , ... August 30, 2015 , ... ... has been promoted from Administrative assistant to Executive Assistant to CEO Mitch Gould ... a proven professional, focused on your goals. Kathleen graduated from Florida State ...
(Date:8/29/2015)... ... August 29, 2015 , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, ... (Meso Foundation) will present an educational program titled “Asbestos and Your Health.” , ... 9:30 PM (doors open at 6:45pm) at Calvary United Methodist Church, 16 E Park ...
(Date:8/29/2015)... ... ... Brands like Toppik , Eau Thermale Avene and Bliss are now available on ... was required to qualify for free standard shipping,” said Jennifer Ramirez, the public relations ... of the item’s selling price.” , With competitive pricing in the e-commerce market for ...
(Date:8/29/2015)... ... August 29, 2015 , ... The popular television program VOICES IN ... announced that it will be devoting an entire short segment to the subject of ... around the globe on a daily basis, but recent advancements in medical science may ...
Breaking Medicine News(10 mins):Health News:Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2
... Health Foundation,s Annual Salute to Service Award , ... second consecutive year, Jim Kerwin of Oxford Communications ( ... announce that Oxford Communications will be the primary sponsor ... Award Luncheon on June 17th and Celebrity Golf Tournament ...
... Agency hopes to better explain its decisions to regain lost ... Food and Drug Administration, an agency long criticized for not ... it has created a task force to study how to ... to try and figure out how to make FDA and ...
... LAUDERDALE, Fla., June 2 LifeSync Corporation, the ... announced that Florida Hospital in Orlando has completed ... its Cardiovascular Institute for patients undergoing cardiovascular surgery. ... in the Florida Hospital System, houses the Florida ...
... This ... health care advocacy but it does little to help the public, says Erika Schwartz, MD ... (PRWEB) June 2, 2009 -- This week,s ... care advocacy but it does little to help the public, says Erika Schwartz, MD in her ...
... PEMBROKE, Bermuda, June 2 Darwin ... Company,Holdings, Ltd (NYSE: AWH ), today ... Manager, will be participating in a,panel at the American ... 3, 2009. The roundtable is titled "Market, Claims,and Healthcare ...
... , MILLERSVILLE, Md., June 2 Travel Advantage Network ... spring morning to support the National Alliance for Research ... kilometers of it. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090602/DC26325 ) ... support the charity by completing a 2.5K sponsored walk at ...
Cached Medicine News:Health News:Jim Kerwin Announces Oxford Communications To Be the Title Sponsor of Bermuda Health Foundation Salute for the Second Year 2Health News:FDA to Study Ways to Be More Open With Public 2Health News:FDA to Study Ways to Be More Open With Public 3Health News:Florida Hospital Cardiovascular Institute Completes House-Wide Implementation of the LifeSync(R) Wireless ECG System 2Health News:Florida Hospital Cardiovascular Institute Completes House-Wide Implementation of the LifeSync(R) Wireless ECG System 3Health News:Dr Erika Says Newsweek's Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 2Health News:Darwin's Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable, June 3, 2009 2Health News:Darwin's Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable, June 3, 2009 3Health News:A Little Bit of Leg Work Goes a Long Way for Travel Advantage Network and Mental Health Charity 2
Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase...
GBM -Ab EIA Auto-Immune Markers 013-GBM-96 Glomerular Basement Membrane...
... Insulin-like growth factor 1 (IGF-1) is a polypeptide ... one of a number of related insulin-like growth ... approximately 50% sequence homology with proinsulin and has ... The peptide is growth hormone (GH) dependent to ...
...
Medicine Products: